Particularly noteworthy, within the TCGA database, SMARCAL1 expression exhibited significant increases in higher-grade Gliomas (Fig. 3C) and IDH-wildtype Gliomas (Fig. 3D), as well as in samples lacking 1p/19q codeletion (Fig. 3E). Here, SMARCAL1 is linked to central nervous system cancer.